Gene · 8658
Papers2,155
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,155
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epistasis regulates genetic control of cardiac hypertrophy. | Nat Cardiovasc Res | 2025 | 40473955 | PubTator, text mining | PubMed |
| Apoptosis and G2/M Phase Cell Cycle Arrest Induced by Alkaloid Erythraline Isolated from Erythrina velutina in SiHa Cervical Cancer Cell. | Int J Mol Sci | 2025 | 40429769 | PubTator, text mining | PubMed |
| Adenosine diphosphate-ribosylation greatly affects proteins function: a focus on neurodegenerative diseases. | Front Aging Neurosci | 2025 | 40370754 | PubTator, text mining | PubMed |
| The upregulation of TNKS1 drives the phenotypic switching of vascular smooth muscle cells in aortic dissection through the activation of ferroptosis. | Int Immunopharmacol | 2025 | 40359887 | PubTator, text mining | PubMed |
| Proteogenomic reprogramming to a functional human blastomere-like stem cell state via a PARP-DUX4 regulatory axis. | Cell Rep | 2025 | 40338744 | PubTator, text mining | PubMed |
| In Silico and In Vitro Analyses of Strawberry-Derived Extracts in Relation to Key Compounds' Metabolic and Anti-Tumor Effects. | Int J Mol Sci | 2025 | 40331930 | PubTator, text mining | PubMed |
| CDX2 downregulation regulates intrinsic WNT pathway activation, dictating metastasis in APC and CTNNB1 wildtype colorectal cancer. | Oncogene | 2025 | 40189705 | PubTator, text mining | PubMed |
| Targeting Latent HIV Reservoirs: Effectiveness of Combination Therapy with HDAC and PARP Inhibitors. | Viruses | 2025 | 40143326 | PubTator, text mining | PubMed |
| Deconstruction of Dual-Site Tankyrase Inhibitors Provides Insights into Binding Energetics and Suggests Critical Hotspots for Ligand Optimization. | J Med Chem | 2025 | 40134122 | PubTator, text mining | PubMed |
| Fungal mediated production of novel metabolites of meloxicam and their tankyrase-2 inhibition potentials: an in silico study. | Int Microbiol | 2025 | 40019717 | PubTator, text mining | PubMed |
| Targeting the PARylation-Dependent Ubiquitination Signaling Pathway for Cancer Therapies. | Biomolecules | 2025 | 40001540 | PubTator, text mining | PubMed |
| Re-evaluation of PTEN as an ADP-ribosylated tankyrase binding partner. | FEBS J | 2025 | 39988758 | PubTator, text mining | PubMed |
| Substitutions at the C-8 position of quinazolin-4-ones improve the potency of nicotinamide site binding tankyrase inhibitors. | Eur J Med Chem | 2025 | 39983556 | PubTator, text mining | PubMed |
| Modulation of β-Catenin promotes WNT expression in macrophages and mitigates intestinal injury. | Cell Commun Signal | 2025 | 39934819 | PubTator, text mining | PubMed |
| Effects of 0.01 mM strontium on human periodontal ligament stem cell osteogenic differentiation via the Wnt/β-catenin signaling pathway. | J Int Med Res | 2025 | 39932304 | PubTator, text mining | PubMed |
| Pharmacophore-based identification and in Silico characterization of microbial metabolites as potential modulators of Wnt signaling pathway in colorectal cancer therapy. | Mol Divers | 2025 | 39921842 | PubTator, text mining | PubMed |
| Decoupled level and flow rate control of a two-tank system in beverage production: A comparative analysis of Fuzzy-PID and GA-PID for minimum time operation. | PLoS One | 2025 | 39908325 | PubTator, text mining | PubMed |
| A quantitative intracellular peptide-binding assay reveals recognition determinants and context dependence of short linear motifs. | J Biol Chem | 2025 | 39864625 | PubTator, text mining | PubMed |
| Understanding Tankyrase Inhibitors and Their Role in the Management of Different Cancer. | Curr Cancer Drug Targets | 2025 | 39754759 | PubTator, text mining | PubMed |
| Novel inhibitors of PARP1 and PARP14: design, synthesis, and potentiation of cisplatin efficacy in cancer. | Future Med Chem | 2025 | 39691063 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8658/papers?page=4